PATENT CLAIM ANALYSIS

Application Number: 16133977
Application Type: Utility
Filing Date: 2018-09
Publication Date: 2019-03
Patent Classification: ["607", "120000"]

Abstract:
Representative embodiments of the present invention provide for novel, minimally invasive implantable devices and methods for targeted tissue drug delivery of cardiovascular drugs.

Claim (Index 11):
The device according to  claim 10 , wherein the anesthetic drug is selected from the group consisting of procaine, lidocaine, a combination of procaine and at least one other anesthetic drug, a combination of lidocaine and at least one other anesthetic drug, and a combination of procaine, lidocaine, and at least one other anesthetic drug.

Metadata:
- Claim Count in Document: 50.0
- Percentile: 97.0
- Lexical Diversity: 1.08696
- Patent Class: 607.0
- Transitional Phrase Type: closed
- Component Type: 1
- Foreign Priority: False
- Related Applications: ['14427607', '10318298', '10679772', '11777283', '10608409']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7300363391681051
- 35 USC 102 Novelty (BERT): 0.5738409600397565
- Combined Prediction Score: 0.7144168012552702
- Mean Citation Score: 283.585152
- Max Citation Score: 473.15042
- Similarity Product: 455.3706336196554

Labels:
- Claim Label 101: 1
- Claim Label 102: 0
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 0
- Label 101 Adjusted: 1

Dataset: test